Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Cocrystal Pharma, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +1 vs. Q3 2023
- Shares held
- 683.4K
- −20.9K (−3.0%) vs. Q3 2023
- Total value
- $1.17M
- −$143.2K (−10.9%) vs. Q3 2023
- New holders
- 2
- 4 more added
- Sold out
- 1
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COCP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.17M |
| Q1 2026 | 26 | $783.8K |
| Q4 2025 | 28 | $754.3K |
| Q3 2025 | 22 | $831.3K |
| Q2 2025 | 22 | $1.02M |
| Q1 2025 | 24 | $1.06M |
| Q4 2024 | 24 | $1.44M |
| Q3 2024 | 20 | $1.27M |
| Q2 2024 | 14 | $1.57M |
| Q1 2024 | 16 | $1.01M |
| Q4 2023 | 17 | $1.17M |
| Q3 2023 | 16 | $1.32M |
| Q2 2023 | 20 | $1.59M |
| Q1 2023 | 21 | $1.47M |
| Q4 2022 | 21 | $2.08M |
| Q3 2022 | 27 | $3.95M |
| Q2 2022 | 33 | $5.83M |
| Q1 2022 | 34 | $7.90M |
| Q4 2021 | 35 | $9.78M |
| Q3 2021 | 41 | $16.1M |
| Q2 2021 | 42 | $25.0M |
| Q1 2021 | 35 | $13.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Cocrystal Pharma, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 9 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 4 | $7 | 0.00% | −183−97.9% | Reduced |
| NVWM, LLC | 84 | $145 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 92 | $159 | 0.00% | +3+3.4% | Added |
| UBS Group AG | 167 | $288 | 0.00% | +167 | New |
| Vima LLC | 225 | $387 | 0.00% | +225 | New |
| JPMorgan Chase & Co | 2,196 | $3.73K | 0.00% | +452+25.9% | Added |
| Tower Research Capital LLC (TRC) | 5,844 | $10.1K | 0.00% | +2,496+74.6% | Added |
| Bank of America Corp | 8,979 | $15.5K | 0.00% | −49−0.5% | Reduced |
| Northern Trust Corp | 12,207 | $21.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 24,443 | $41.6K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 34,544 | $58.7K | 0.00% | −37,635−52.1% | Reduced |
| Morgan Stanley | 59,277 | $102.1K | 0.00% | +14,824+33.3% | Added |
| Geode Capital Management, LLC | 60,432 | $102.8K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 74,063 | $127.6K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 125,128 | $215.0K | 0.00% | −1,100−0.9% | Reduced |
| Vanguard Group Inc | 275,656 | $474.7K | 0.00% | 00.0% | Unchanged |
| Archer Investment Corp | 0 | $0 | 0.00% | −84−100.0% | Sold out |